Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Invest New Drugs. 2013 Feb 9;31(4):986–1000. doi: 10.1007/s10637-012-9921-8

Fig. 1.

Fig. 1

a Characterization of CRLX101 - self assembly of CDP-CPT conjugates into nanoparticles. b Characterization of CRLX101 -enhanced tumor permeability